Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Infante

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Neurology. Genetics|June 9, 2023
Cumulative Genetic Score and John Dou, Kelly Bakulski, Kai Guo, et al.
Neurology. Genetics|July 31, 2023
Erratum: Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control StudiesJohn Dou, Kelly Bakulski, Kai Guo, et al.
Parkinsonism & Related Disorders|June 18, 2021
In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS studyMichel J Grothe, Miguel A Labrador-Espinosa, Silvia Jesús, et al.
Brain : a Journal of Neurology|December 20, 2024
In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson's diseaseAdriana Cortés, Toan K Phung, Lorena de Mena, et al.
The Lancet. Neurology|September 18, 2015
Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort studyHeike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 19, 2019
Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar AtaxiaAlhassane Diallo, Heike Jacobi, Arron Cook, et al.
Neurobiology of Aging|September 3, 2020
Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's diseaseEmmeline E Brown, Cornelis Blauwendraat, Joanne Trinh, et al.
Journal of Medical Genetics|May 1, 2014
Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6Sophie Tezenas du Montcel, Alexandra Durr, Maria Rakowicz, et al.
Journal of Neurology|July 1, 2018
Long-term evolution of patient-reported outcome measures in spinocerebellar ataxiasHeike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, et al.
Annals of Neurology|November 14, 2023
Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3Jennifer Faber, Moritz Berger, Carlo Wilke, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Neurology. Genetics|June 9, 2023
Cumulative Genetic Score and John Dou, Kelly Bakulski, Kai Guo, et al.
Neurology. Genetics|July 31, 2023
Erratum: Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control StudiesJohn Dou, Kelly Bakulski, Kai Guo, et al.
Parkinsonism & Related Disorders|June 18, 2021
In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS studyMichel J Grothe, Miguel A Labrador-Espinosa, Silvia Jesús, et al.
Brain : a Journal of Neurology|December 20, 2024
In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson's diseaseAdriana Cortés, Toan K Phung, Lorena de Mena, et al.
The Lancet. Neurology|September 18, 2015
Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort studyHeike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 19, 2019
Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar AtaxiaAlhassane Diallo, Heike Jacobi, Arron Cook, et al.
Neurobiology of Aging|September 3, 2020
Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's diseaseEmmeline E Brown, Cornelis Blauwendraat, Joanne Trinh, et al.
Journal of Medical Genetics|May 1, 2014
Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6Sophie Tezenas du Montcel, Alexandra Durr, Maria Rakowicz, et al.
Journal of Neurology|July 1, 2018
Long-term evolution of patient-reported outcome measures in spinocerebellar ataxiasHeike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, et al.
Annals of Neurology|November 14, 2023
Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3Jennifer Faber, Moritz Berger, Carlo Wilke, et al.
Pageof 15